Unlock instant, AI-driven research and patent intelligence for your innovation.

A method for inactivating feeder cells combined with cytokines to stimulate NK cell expansion

A feeder cell and cytokine technology, applied in the field of cell culture, can solve the problems of incomplete inactivation, high test cost and high requirements, and achieve the effects of good targeted killing of tumor cells, high killing activity and fast proliferation rate.

Active Publication Date: 2022-07-05
青岛麦迪赛斯生物科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Radiation can completely inactivate, but it has high requirements for equipment and high test cost; the method of repeated freezing and thawing has low requirements for test equipment, but the inactivation is not complete, and repeated operations are required, and it is difficult to maintain the integrity of cell morphology. Affect NK stimulation effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for inactivating feeder cells combined with cytokines to stimulate NK cell expansion
  • A method for inactivating feeder cells combined with cytokines to stimulate NK cell expansion

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] 1 Isolation of PBMC: Collect 50ml of peripheral blood from tumor patients, anticoagulated with heparin, and centrifuge the whole blood at 700g for 20min. The upper layer is the plasma layer, the middle layer is the buffy coat, and the lower layer is the red blood cells. The plasma layer was collected, inactivated at 56°C for 30min, then stood at 4°C for 15min, 1800rpm / 800g, 4°C, 25min, and the supernatant was used as autologous plasma for later use. Collect the intermediate buffy coat layer, add it to 20ml PBS, mix well, and then slowly add the centrifuge tube to which the lymphatic separation medium has been added at a ratio of 4:3, 1800rpm / 800g, room temperature, 20min, no-break, wash PBMC; After centrifugation, the white PBMC layer in the middle was sucked out by a Steer pipette, and about 30 ml of PBS was added to a new 50 ml centrifuge tube for washing, 1500 rpm, 8 min, washed once with culture medium, and counted.

[0025] 2. Induction and expansion of NK cells: ...

Embodiment 2

[0031] 1 Isolate PBMCs

[0032]50ml of peripheral blood was collected from tumor patients, anticoagulated with heparin, and whole blood was centrifuged at 700g for 20min. The upper layer is the plasma layer, the middle layer is the buffy coat, and the lower layer is the red blood cells. The plasma layer was collected, inactivated at 56°C for 30min, then stood at 4°C for 15min, 1800rpm / 800g, 4°C, 25min, and the supernatant was used as autologous plasma for later use. Collect the intermediate buffy coat layer, add it to 20ml PBS, mix well, and then slowly add the centrifuge tube to which the lymphatic separation medium has been added at a ratio of 4:3, 1800rpm / 800g, room temperature, 20min, no-break, wash PBMC; After centrifugation, the white PBMC layer in the middle was sucked out by a Steer pipette, and about 30 ml of PBS was added to a new 50 ml centrifuge tube to wash, 1500 rpm, 8 min, washed once with medium, and counted.

[0033] 2 Induction and expansion of NK cells

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The purpose of the present invention is to provide a novel method for inactivating recombinant K562 cells combined with cytokine combination to stimulate NK cell expansion. The NK cells prepared by the present invention have high purity and killing activity. After testing, the purity of NK cells reaches more than 90% when cultured for 14 days; when the effect-target ratio is 10:1, the killing activity of NK cells on K562 cells above 80%. The NK cells prepared by the invention have a fast proliferation rate, and the cell expansion multiples of 14-17 days after being cultured reach more than 500. The NK cells prepared by the invention have a good effect of targeting and killing tumor cells.

Description

technical field [0001] The invention belongs to the technical field of cell culture, in particular to a method for inactivating feeder cells combined with cytokines to stimulate the expansion of NK cells (Natural killer cells). Background technique [0002] Currently, cancer has become the number one cause of death in the world. Conventional methods of cancer treatment include surgery, radiotherapy and chemotherapy. Immune cell therapy is the fourth new way to treat tumors after surgery, chemotherapy and radiotherapy. It can systematically kill tumor cells, effectively inhibit the metastasis of tumor cells, with few side effects and good clinical effects. [0003] The clinical application of immune cell therapy includes DC cells, CIK cells, DC-CIK cells and NK cells. NK cells are the third type of lymphocytes. Different from T / B lymphocytes, they can exert cytotoxic effects without antigen stimulation. They can spontaneously lyse a variety of tumor cells and virus-infected...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0783
CPCC12N5/0646C12N2502/30C12N2501/515C12N2501/599C12N2501/2302
Inventor 葛淑娟徐矫健刘燕丽王玉娟
Owner 青岛麦迪赛斯生物科技有限公司